Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02768558
Title Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors RTOG Foundation, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
Stanford University Stanford California 94305 United States Details
University of Florida Gainesville Florida 32610 United States Details
Mount Sinai Cancer Research Center Miami Beach Florida 33140 United States Details
Nancy N. & J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler Hospital Savannah Georgia 31405 United States Details
University of Kentucky Lexington Kentucky 40536 United States Details
Mercy Medical Cancer Center Baltimore Maryland 21202 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Rochester Rochester New York 14642 United States Details
Metro Health Medical Center Cleveland Ohio 44109 United States Details
Reading Hospital/McGlinn Cancer Institute West Reading Pennsylvania 19611 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
Inova Fairfax Hospital Falls Church Virginia 22042 United States Details
Virginia Mason Seattle Washington 98101 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field